Available from: 16
The prescription medication has a list price of $1,027.51 per month, which equals about $256.88 weekly or up to $12,330.12 annually, and that amount is the same for all doses of the drug (0.25 mg, 0.5 mg, 1 mg, 2 mg)
10.1111/j.1476-5381.2009.00441.x [DOI] [PMC free article] [PubMed] [Google Scholar] Coskun T, Sloop KW, Loghin C, Alsina-Fernandez J, Urva S, Bokvist KB, Cui X, Briere DA, Cabrera O, Roell WC, Kuchibhotla U, Moyers JS, Benson CT, Gimeno RE, DAlessio DA, Haupt A (2018) LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept
The researchers noted that even without weight loss, GLP-1 drugs and MHRMs may help lower blood pressure
These studies concludes that dasiglucagon is a potential treatment for PBH [71, 72]
While psychological interventions, such as cognitive behavioral therapy, primarily deal with emotional and behavioral aspects of the disorder, pharmacological interventions mainly involve selective serotonin reuptake inhibitors to manage the symptoms